EA201490626A1 - Поэтапное дозирование клопидогрела - Google Patents
Поэтапное дозирование клопидогрелаInfo
- Publication number
- EA201490626A1 EA201490626A1 EA201490626A EA201490626A EA201490626A1 EA 201490626 A1 EA201490626 A1 EA 201490626A1 EA 201490626 A EA201490626 A EA 201490626A EA 201490626 A EA201490626 A EA 201490626A EA 201490626 A1 EA201490626 A1 EA 201490626A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- gradual dosing
- gradual
- dosing
- clopidogrel
- stroke
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение касается новых препаратов клопидогрела, обеспечивающих поэтапное/с интервалами высвобождение, для применения в качестве улучшенных антитромбоцитарных терапевтических средств при инсульте и сердечно-сосудистых показаниях.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161534648P | 2011-09-14 | 2011-09-14 | |
PCT/US2012/055550 WO2013040442A1 (en) | 2011-09-14 | 2012-09-14 | Phased dosing of clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201490626A1 true EA201490626A1 (ru) | 2014-08-29 |
Family
ID=47883794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201490626A EA201490626A1 (ru) | 2011-09-14 | 2012-09-14 | Поэтапное дозирование клопидогрела |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150024042A1 (ru) |
EP (1) | EP2755979A4 (ru) |
CN (1) | CN103917544A (ru) |
BR (1) | BR112014006124A2 (ru) |
CA (1) | CA2848756A1 (ru) |
EA (1) | EA201490626A1 (ru) |
MX (1) | MX2014003214A (ru) |
WO (1) | WO2013040442A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105218559A (zh) * | 2015-10-21 | 2016-01-06 | 云南省药物研究所 | 一种稳定的非晶态硫酸氢氯吡格雷复合物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7029701B2 (en) * | 2000-09-11 | 2006-04-18 | Andrx Pharmaceuticals, Llc | Composition for the treatment and prevention of ischemic events |
US20060210633A1 (en) * | 2003-04-03 | 2006-09-21 | Sun Pharmaceutical Industries Limited | Programmed drug delivery system |
US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
US20070003615A1 (en) * | 2005-06-13 | 2007-01-04 | Elan Pharma International Limited | Nanoparticulate clopidogrel and aspirin combination formulations |
FR2887455B1 (fr) * | 2005-06-28 | 2007-08-10 | Sanofi Aventis Sa | Formulation a liberation prolongee de principes actifs de medicaments |
JP5844028B2 (ja) * | 2006-04-04 | 2016-01-13 | ケージー アクキュイシチオン エルエルシー | 抗血小板薬及び酸阻害薬を含む経口剤形 |
WO2007113857A2 (en) * | 2006-04-05 | 2007-10-11 | Cadila Healthcare Limited | Modified release clopidogrel formulation |
WO2007122636A1 (en) * | 2006-04-25 | 2007-11-01 | Panacea Biotec Ltd | Pharmaceutical compositions containing long chain fatty acids as excipients as well as a process for manufacturing the same |
WO2009104932A2 (ko) * | 2008-02-22 | 2009-08-27 | 한올제약주식회사 | 복합제제 |
CN101703513B (zh) * | 2009-11-10 | 2014-04-23 | 沈阳药科大学 | 阿司匹林和氯吡格雷或其药学上可接受的盐的复方缓释制剂 |
GB201003731D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
-
2012
- 2012-09-14 MX MX2014003214A patent/MX2014003214A/es not_active Application Discontinuation
- 2012-09-14 CA CA 2848756 patent/CA2848756A1/en not_active Abandoned
- 2012-09-14 CN CN201280053839.0A patent/CN103917544A/zh active Pending
- 2012-09-14 BR BR112014006124A patent/BR112014006124A2/pt not_active Application Discontinuation
- 2012-09-14 EA EA201490626A patent/EA201490626A1/ru unknown
- 2012-09-14 US US14/344,699 patent/US20150024042A1/en not_active Abandoned
- 2012-09-14 WO PCT/US2012/055550 patent/WO2013040442A1/en active Application Filing
- 2012-09-14 EP EP12830993.7A patent/EP2755979A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MX2014003214A (es) | 2014-12-05 |
CN103917544A (zh) | 2014-07-09 |
WO2013040442A1 (en) | 2013-03-21 |
US20150024042A1 (en) | 2015-01-22 |
EP2755979A1 (en) | 2014-07-23 |
BR112014006124A2 (pt) | 2017-04-11 |
EP2755979A4 (en) | 2015-06-17 |
CA2848756A1 (en) | 2013-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34721A (es) | Anticuerpos anti-hla-b*27 y usos de éstos. | |
EA201491811A1 (ru) | АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ | |
IN2015DN00127A (ru) | ||
HK1205141A1 (en) | Anti-pcsk9 antibodies, formulations, dosing, and methods of use -pcsk9 | |
AU340311S (en) | Toy | |
EA201491947A1 (ru) | Антитела и иммуноконъюгаты к ly6e и способы применения | |
BR112013025742A2 (pt) | composição de vidros bioativos, sua utilização e respectivo métodos de obtenção. | |
BR112015009718A2 (pt) | composição de matéria e artigo. | |
BR112014009802A2 (pt) | composições de bismaleimida contendo nanossílica | |
EA201491357A1 (ru) | Анти-lrp5 антитела и способы их применения | |
SG11201502264SA (en) | Stable metal compounds, their compositions and methods of their use | |
JO3154B1 (ar) | عوامل مضادة لـ trpv4 | |
ES2972198T3 (es) | Formulaciones de bromocriptina | |
MX345926B (es) | Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas. | |
BR112013030853A2 (pt) | composição compreendendo extrato de pendúculo de caju. | |
UY4181Q (es) | Taza | |
BR112014000255A2 (pt) | composição de suplemento de ferro | |
IL233627A0 (en) | Aldehydes as perfumes | |
UY34099A (es) | ?composición de agentes de coalescencia?. | |
BR112015000468A2 (pt) | composição detergente | |
EA201492280A1 (ru) | Стабильный состав пексиганана | |
BR112014028441A2 (pt) | composição de proteína | |
UY34613A (es) | Composición de limpieza | |
EA201490626A1 (ru) | Поэтапное дозирование клопидогрела | |
FR2971397B1 (fr) | Recifs artificiels notamment pour especes sedentaires |